ArticleMaterials (Basel, Switzerland)2025
Study on Antibacterial Powder Coatings Based on Halloysite/Biopolymer Compounds.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
This study presents an eco-friendly approach to antibacterial polyester powder coatings by incorporating hybrid additives composed of biopolymers immobilized on halloysite nanotubes. Polylysine (PLY) and quaternized chitosan (CH-Q) were used as natural antimicrobial agents, while halloysite (HAL) acted as a carrier to improve dispersion and reduce leaching. HAL/PLY and HAL/CH-Q hybrids were incorporated into polyester coatings and evaluated for morphology, mechanical properties, water resistance, and antibacterial performance (ISO 22196). The HAL/PLY coating demonstrated a strong bactericidal effect, reducing Escherichia coli and Staphylococcus aureus by 99.9989% and 99.9993%, respectively. HAL/CH-Q showed moderate activity against
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.